Raloxifene is a selective estrogen receptor modulator. It mimics the beneficial effects of
estrogen on the bones. Raloxifene increases bone mass and reduces the risk of spine
fractures. It is indicated for the prevention and treatment of osteoporosis in
postmenopausal women.
To learn more about this product, open the patient information provided by MedlinePlus
(U.S. National Library of Medicine):
Raloxifene Consumer Information
or read the monograph for Raloxifene provided by RxList.com:
Raloxifene Monograph
Evista® is a registered trademark of Eli Lilly and Company.
Best Online Pharmacies Offering Generic Evista
|
This information is for educational purposes only and should not be used as a substitute for
the advice of a licensed physician. Please consult a licensed health care provider regarding
your medical condition. For USA orders the Food and Drug Administration (FDA) requires an
online prescription from a qualified medical practitioner to cover the purchase of
prescription medications.
Top Generic Drugs, Copyright 2004-2008
Osteoporosis Drugs
Generic Evista (Raloxifene)